Yarlagadda S. Babu
2018
Compensation breakdown
| Non-Equity Incentive Plan | $180,600 |
|---|---|
| Option Awards | $1,141,160 |
| Salary | $420,000 |
| Other | $13,750 |
| Total | $1,755,510 |
Babu received $1.1M in option awards, accounting for 65% of the total pay in 2018.
Babu also received $180.6K in non-equity incentive plan, $420K in salary and $13.8K in other compensation.
Rankings
In 2018, Yarlagadda S. Babu's compensation ranked 6,378th out of 14,244 executives tracked by ExecPay. In other words, Babu earned more than 55.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,378 out of 14,244 | 55th |
Division Manufacturing | 2,438 out of 5,765 | 58th |
Major group Chemicals And Allied Products | 908 out of 2,128 | 57th |
Industry group Drugs | 763 out of 1,817 | 58th |
Industry Biological Products, Except Diagnostic Substances | 149 out of 339 | 56th |
Pay ratio
| Yarlagadda S. Babu's Pay | $1,755,510 |
|---|---|
| Median Employee's Pay | $205,224 |
| Pay Ratio | 9to 1 |
In 2018, the annual total compensation of Yarlagadda S. Babu was $1,755,510.
The annual total compensation of the median employee at BioCryst Pharmaceuticals was $205,224.
The ratio of Yarlagadda S. Babu's pay to the pay of median employee was therefore 9 to one.
Babu's colleagues
We found four more compensation records of executives who worked with Yarlagadda S. Babu at BioCryst Pharmaceuticals in 2018.
2018
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2018
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2018
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2018
Lynne Powell
BioCryst Pharmaceuticals